Abstract
Introduction: Liver cirrhosis is a progressive chronic liver disease characterized by fibrosis and architectural distortion, leading to complications such as portal hypertension, ascites, encephalopathy, and esophageal varices. As the prevalence of viral and metabolic liver diseases changes globally, understanding regional etiological patterns is essential.
Methods: In this retrospective cross-sectional study, 200 patients with confirmed liver cirrhosis were evaluated using hospital records. Demographic characteristics, substance use, etiology, complications, and hospitalization outcomes were analyzed using SPSS v26. Statistical significance was defined as p<0.05.
Results: Nonalcoholic steatohepatitis (NASH) was the most common cause of cirrhosis (44.1%), followed by hepatitis B (20.6%), autoimmune hepatitis/PSC (10.8%), alcoholic liver disease (9.3%), and hepatitis C (8.8%). Wilson disease and cardiac cirrhosis were rare. Etiology differed significantly across age groups (p=0.003), but not by sex or clinical outcome. Portal hypertension was the most frequent complication (≈94%), followed by ascites (34.8%) and esophageal varices (26.5%). Overall mortality was 19%, while hospitalization duration and frequency did not vary significantly among etiological groups.
Conclusion: NASH has become the leading cause of liver cirrhosis in this population, reflecting the growing impact of metabolic disorders. These findings emphasize the importance of preventive strategies, lifestyle modification, and effective management of metabolic risk factors to reduce the burden of cirrhosis.
References 37
-
[1] Sharma B, John S. Hepatic cirrhosis. 2018.
-
[2] Yang X, Li Q, Liu W, Zong C, Wei L, Shi Y, et al. Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment. Cellular & Molecular Immunology. 2023;20(6):583-99.
-
[3] Schuppan D, Afdhal NH. Liver cirrhosis. The Lancet. 2008;371(9615):838-51.
-
[4] Wanless IR. Physioanatomic considerations. Schiff's Diseases of the Liver. 2011:87-119.
-
[5] Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, et al. Global epidemiology of cirrhosis---aetiology, trends and predictions. Nature reviews Gastroenterology & hepatology. 2023;20(6):388-98.
-
[6] Rashidpanah M, Abolghasemi J, Toosi MN, Salehi M. Investigating the different stages in the progress of cirrhosis using the Markov model. Govaresh. 2016;21(3):157-66.
-
[7] Hajiani E, Hashemi S, Masjedizadeh R, Ahmadzadeh S. Liver cirrhosis seen in GI clinics of Ahvaz, Iran. Govaresh. 2012;17(3):178-82.
-
[8] Ganji A, Malekzadeh F, Safavi M, Nassri-Moghaddam S, Nourie M, Merat S, et al. Digestive and liver disease statistics in Iran. Middle East Journal of Digestive Diseases (MEJDD). 2009;1(2):56-62.
-
[9] Cheemerla S, Balakrishnan M. Global epidemiology of chronic liver disease. Clinical liver disease. 2021;17(5):365-70.
-
[10] Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537-64.
-
[11] Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. Journal of hepatology. 2019;70(1):151-71.
-
[12] Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell metabolism. 2022;34(7):969-77.
-
[13] Orman ES, Roberts A, Ghabril M, Nephew L, Desai AP, Patidar K, et al. Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis. JAMA Netw Open. 2019;2(6):e196412.
-
[14] Ramírez-Soto MC, Salazar-Peña M, Vargas-Herrera J. Estimating excess mortality due to prostate, breast, and uterus cancer during the COVID-19 pandemic in Peru: a time series analysis. International journal of environmental research and public health. 2023;20(6):5156.
-
[15] Scorza M, Elce A, Zarrilli F, Liguori R, Amato F, Castaldo G. Genetic diseases that predispose to early liver cirrhosis. International Journal of Hepatology. 2014;2014(1):713754.
-
[16] Ronnenberg A. Risk Factors for Cirrhosis.
-
[17] Chen VL, Yeh ML, Le AK, Jun M, Saeed WK, Yang JD, et al. Anti‐viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus‐related hepatocellular carcinoma: real‐world east and west experience. Alimentary pharmacology & therapeutics. 2018;48(1):44-54.
-
[18] Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371(9615):838-51.
-
[19] Lim YS, Kim WR. The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis. 2008;12(4):733-46, vii.
-
[20] Zhai M, Long J, Liu S, Liu C, Li L, Yang L, et al. The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017. Aging (Albany NY). 2021;13(1):279-300.
-
[21] Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, Hutin YJ, et al. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. The Lancet Gastroenterology & Hepatology. 2022;7(8):724-35.
-
[22] Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529-38.
-
[23] Jepsen P, Younossi ZM. The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs. J Hepatol. 2021;75 Suppl 1:S3-s13.
-
[24] Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, et al. Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023;20(6):388-98.
-
[25] Sajja KC, Mohan DP, Rockey DC. Age and ethnicity in cirrhosis. J Investig Med. 2014;62(7):920-6.
-
[26] Hester CA, Rich NE, Singal AG, Yopp AC. Comparative Analysis of Nonalcoholic Steatohepatitis- Versus Viral Hepatitis- and Alcohol-Related Liver Disease-Related Hepatocellular Carcinoma. J Natl Compr Canc Netw. 2019;17(4):322-9.
-
[27] Michitaka K, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M. Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2010;45(1):86-94.
-
[28] Sagnelli E, Stroffolini T, Sagnelli C, Pirisi M, Babudieri S, Colloredo G, et al. Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy. Infection. 2018;46(1):93-101.
-
[29] Stroffolini T, Sagnelli E, Andriulli A, Colloredo G, Furlan C, Gaeta GB, et al. Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis. PLoS One. 2017;12(11):e0185710.
-
[30] Chowdhury N, Ahmad M, Bajwa M, Bank L, Hila A. S1090 Correlations Between Biomarkers and Hospital Length of Stay and 30-Day Readmission in Patients With Decompensated Liver Cirrhosis in a Community Health System. Official journal of the American College of Gastroenterology | ACG. 2020;115.
-
[31] Gala K, Vatsalya V. Tu1631 ASSOCIATION OF HYPOMAGNESEMIA WITH LIVER INJURY, GUT BARRIER DYSFUNCTION AND INFLAMMATION; AND EFFICACY OF MEDICAL MANAGEMENT IN EARLY ALCOHOLIC LIVER DISEASE2020. S-1439 p.
-
[32] Çavuşoğlu Türker B, Sahin T, Türker F. Evaluation of Patients with Hepatic Cirrhosis due to Etiology for the Complication. DAHUDER Medical Journal. 2024;4.
-
[33] Sivanathan V, Kittner JM, Sprinzl MF, Weinmann A, Koch S, Wiltink J, et al. [Etiology and complications of liver cirrhosis: data from a German centre]. Dtsch Med Wochenschr. 2014;139(36):1758-62.
-
[34] Topdagi O, Okcu N, Bilen N. The frequency of complications and the etiology of disease in patients with liver cirrhosis in erzurum. Eurasian J Med. 2014;46(2):110-4.
-
[35] Kim D, Li AA, Perumpail BJ, Gadiparthi C, Kim W, Cholankeril G, et al. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States. Hepatology. 2019;69(3):1064-74.
-
[36] Ye F, Zhai M, Long J, Gong Y, Ren C, Zhang D, et al. The burden of liver cirrhosis in mortality: Results from the global burden of disease study. Front Public Health. 2022;10:909455.
-
[37] Hagström H, Lindfors A, Holmer M, Bengtsson B, Björkström K, Hegmar H, et al. Etiologies and outcomes of cirrhosis in a large contemporary cohort. Scand J Gastroenterol. 2021;56(6):727-32.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Melika Mousavi, Atabak Sedigh-Namin, Somaieh Matin, Shafagh Aliasgarzadeh, nazli javaheri (Author)